Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model

Journal of Physiology

Volumn 594, Issue 15, 2016, Pages 4309-4323

  Brégeon, Jérémy ^a,b,c   Coron, Emmanuel ^a,b,c   Da Silva, Anna Christina Cordeiro ^a,b,c   Jaulin, Julie ^a,b,c   Aubert, Philippe ^a,b,c   Chevalier, Julien ^a,b,c   Vergnolle, Nathalie ^d   Meurette, Guillaume ^a,b,c   Neunlist, Michel ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c HÔTEL DIEU   (France)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAX PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; MEMBRANE PROTEIN; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA1; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; IMAGING; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTESTINE MUCOSAL INJURY; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; PIG; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SACRAL NERVE STIMULATION; TISSUE REPAIR; TRANSCRIPTOMICS;

EID: 84979884683     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271783     Document Type: Article

References (54)

1. Andújar I, Ríos JL, Giner RM & Recio MC (2013). Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells. Eur J Pharm Sci 49, 637–641.
2. Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T & Bueno L (2013). Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Am J Gastroenterol 108, 1322–1331.
3. Arrieta MC, Madsen K, Doyle J & Meddings J (2009). Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58, 41–48.
4. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, Tilg H, Watson A & Wells JM (2014). Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol 14, 189.
5. Brenna Ø, Furnes MW, Drozdov I, van Beelen Granlund A, Flatberg A, Sandvik AK, Zwiggelaar RTM, Mårvik R, Nordrum IS, Kidd M & Gustafsson BI (2013). Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and transcriptomic [corrected] characterization and correlation to IBD. PloS One 8, e54543.
6. Catalioto R-M, Maggi CA & Giuliani S (2011). Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem 18, 398–426.
7. Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J & Bueno L (2004). PAR2 activation alters colonic paracellular permeability in mice via IFN-dependent and -independent pathways. J Physiol 558, 913–925.
8. Cenac N, Coelho A-M, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L & Vergnolle N (2002). Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161, 1903–1915.
9. Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, Heymann M-F, Neunlist M & Derkinderen P (2015). Structural alterations of the intestinal epithelial barrier in Parkinson's disease. Acta Neuropathol Commun 3, 12.
10. Colgan SP, Resnick MB, Parkos CA, Delp-Archer C, McGuirk D, Bacarra AE, Weller PF & Madara JL (1994). IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 153, 2122–2129.
11. Coron E, Dewitte M, Aubert P, Musquer N, Neunlist M & Bruley des Varannes S (2015). Reversibility of gastric mucosal lesions induced by sodium phosphate tablets and characterized by probe-based confocal laser endomicroscopy. Endosc Int Open 3, E69–E75.
12. Costantini TW, Bansal V, Krzyzaniak M, Putnam JG, Peterson CY, Loomis WH, Wolf P, Baird A, Eliceiri BP & Coimbra R (2010). Vagal nerve stimulation protects against burn-induced intestinal injury through activation of enteric glia cells. Am J Physiol Gastrointest Liver Physiol 299, G1308–G1318.
13. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel J-F, Vermeire S, Travis S, Lindsay JO & Van Assche G (2012). Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis. J Crohns Colitis 6, 965–990.
14. Dignass AU & Podolsky DK (1993). Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105, 1323–1332.
15. Fournier BM & Parkos CA (2012). The role of neutrophils during intestinal inflammation. Mucosal Immunol 5, 354–366.
16. Furness JB (2012). The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9, 286–294.
17. Gandarillas M & Bas F (2009). The domestic pig (Sus scrofa domestica) as a model for evaluating nutritional and metabolic consequences of bariatric surgery practiced on morbid obese humans. Cienc E Investig Agrar 36, 163–176.
18. Groschwitz KR & Hogan SP (2009). Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124, 3–22.
19. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L & Hansson GC (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105, 15064–15069.
20. Kiesslich R, Goetz M, Lammersdorf K, Schneider C, Burg J, Stolte M, Vieth M, Nafe B, Galle PR & Neurath MF (2007). Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132, 874–882.
21. Van Landeghem L, Chevalier J, Mahé MM, Wedel T, Urvil P, Derkinderen P, Savidge T & Neunlist M (2011). Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF. Am J Physiol Gastrointest Liver Physiol 300, G976–G987.
22. Leeb SN, Vogl D, Gunckel M, Kiessling S, Falk W, Göke M, Schölmerich J, Gelbmann CM & Rogler G (2003). Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase1. Gastroenterology 125, 1341–1354.
23. Leoni G, Neumann P-A, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, Argyris I, Rijcken E, Kusters D, Reutelingsperger C, Perretti M, Parkos CA, Farokhzad OC, Neish AS & Nusrat A (2015). Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest 125, 1215–1227.
24. Li C-Q, Xie X-J, Yu T, Gu X-M, Zuo X-L, Zhou C-J, Huang W-Q, Chen H & Li Y-Q (2010). Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am J Gastroenterol 105, 1391–1396.
25. Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P & Hansen AK (2007). The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev 31, 728–751.
26. Lopetuso LR, Scaldaferri F, Bruno G, Petito V, Franceschi F & Gasbarrini A (2015). The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci 19, 1068–1076.
27. Ma Y, Semba S, Khan RI, Bochimoto H, Watanabe T, Fujiya M, Kohgo Y, Liu Y & Taniguchi T (2013). Focal adhesion kinase regulates intestinal epithelial barrier function via redistribution of tight junction. Biochim Biophys Acta 1832, 151–159.
28. Matthijsen RA, Derikx JPM, Kuipers D, van Dam RM, Dejong CHC & Buurman WA (2009). Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammation. PloS One 4, e7045.
29. Meurette G, Blanchard C, Duchalais-Dassonneville E, Coquenlorge S, Aubert P, Wong M, Lehur P-A & Neunlist M (2012). Sacral nerve stimulation enhances epithelial barrier of the rectum: results from a porcine model. Neurogastroenterol Motil 24, 267–210.
30. Musquer N, Coquenlorge S, Bourreille A, Aubert P, Matysiak-Budnik T, des Varannes SB, Lauwers G, Neunlist M & Coron E (2013). Probe-based confocal laser endomicroscopy: a new method for quantitative analysis of pit structure in healthy and Crohn's disease patients. Dig Liver Dis 45, 487–492.
31. Negaard A, Loberg EM, Naess PA, Eriksen M & Klow N-E (2010). Feasibility of MRI in experimentally induced inflammatory small bowel disease: a pilot study in a porcine model. Dig Dis Sci 55, 14–20.
32. Neunlist M, Van Landeghem L, Mahé MM, Derkinderen P, des Varannes SB & Rolli-Derkinderen M (2013). The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol 10, 90–100.
33. Neunlist M, Toumi F, Oreschkova T, Denis M, Leborgne J, Laboisse CL, Galmiche J-P & Jarry A (2003). Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 285, G1028–G1036.
34. Neurath MF & Travis SPL (2012). Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61, 1619–1635.
35. Owen KA, Abshire MY, Tilghman RW, Casanova JE & Bouton AH (2011). FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PloS One 6, e23123.
36. Pastorelli L, De Salvo C, Mercado JR, Vecchi M & Pizarro TT (2013). Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol 4, 280; doi: 10.3389/fimmu.2013.00280.
37. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP & Neunlist M (2009). Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58, 196–201.
38. Pontell L, Castelucci P, Bagyánszki M, Jovic T, Thacker M, Nurgali K, Bron R & Furness JB (2009). Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Arch 455, 55–65.
39. Porras M, Martín MT, Yang P-C, Jury J, Perdue MH & Vergara P (2006). Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis 12, 843–852.
40. Provost M, Brégeon J, Aubert P, Duchalais-Dassonneville E, D'Alembert E, Vergnolle N, Neunlist M & Meurette G (2015). Effects of 1-week sacral nerve stimulation on the rectal intestinal epithelial barrier and neuromuscular transmission in a porcine model. Neurogastroenterol Motil 27, 40–50.
41. Di Sabatino A, Pender SLF, Jackson CL, Prothero JD, Gordon JN, Picariello L, Rovedatti L, Docena G, Monteleone G, Rampton DS, Tonelli F, Corazza GR & MacDonald TT (2007). Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 133, 137–149.
42. Salim SY & Söderholm JD (2011). Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 17, 362–381.
43. Salmela MT, Pender SLF, Karjalainen-Lindsberg M-L, Puolakkainen P, Macdonald TT & Saarialho-Kere U (2004). Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39, 1095–1104.
44. Schürmann G, Brüwer M, Klotz A, Schmid KW, Senninger N & Zimmer KP (1999). Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis 14, 41–46.
45. Söderholm JD, Streutker C, Yang P-C, Paterson C, Singh PK, McKay DM, Sherman PM, Croitoru K & Perdue MH (2004). Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor α. Gut 53, 1817–1824.
46. Soehnlein O & Lindbom L (2010). Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10, 427–439.
47. Swystun VA, Renaux B, Moreau F, Wen S, Peplowski MA, Hollenberg MD & MacNaughton WK (2009). Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Cζ. Am J Physiol Gastrointest Liver Physiol 297, G60–G70.
48. Taupin D & Podolsky DK (2003). Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4, 721–732.
49. Walsh MF, Ampasala DR, Hatfield J, Vander Heide R, Suer S, Rishi AK & Basson MD (2008). Transforming growth factor-β stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am J Pathol 173, 385–399.
50. Walsh SV, Hopkins AM, Chen J, Narumiya S, Parkos CA & Nusrat A (2001). Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterology 121, 566–579.
51. White MJV, Glenn M & Gomer RH (2013). Trypsin potentiates human fibrocyte differentiation. PloS One 8, e70795.
52. Wilcz-Villega E, McClean S & O'Sullivan M (2014). Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS. Neurogastroenterol Motil 26, 316–325.
53. Wyatt J, Vogelsang H, Hübl W, Waldhöer T & Lochs H (1993). Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341, 1437–1439.
54. Yamada Y, Mashima H, Sakai T, Matsuhashi T, Jin M & Ohnishi H (2013). Functional roles of TGF-β1 in intestinal epithelial cells through Smad-dependent and non-Smad pathways. Dig Dis Sci 58, 1207–1217.